Amyloidosis Research Consortium (ARC)
Non-profit OrganizationsMassachusetts, United States11-50 Employees
The Amyloidosis Research Consortium (ARC) is a nonprofit organization based in Newton, Massachusetts that focuses on advancing research and clinical trials for systemic amyloid diseases. It aims to accelerate the development of diagnostic tools and innovative therapies by fostering a collaborative research model that brings together experts from academia, industry, foundations, federal funders, and regulators. ARC targets researchers, clinicians, patients, and partner organizations within the amyloidosis community, addressing gaps in trial design and translational research while building a prioritized portfolio of projects. The organization emphasizes stakeholder engagement and collaborative partnerships to improve diagnosis, care pathways, and ultimately patient outcomes, supported by ongoing programs and initiatives such as ASPIRE, a recent partnership framework launched to enhance impact and equity in the field.